denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: ASH-a-Palooza
Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Workforce
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Workforce
Friday, December 6, 2024: 1:30 PM-3:50 PM
Café Sevilla Restaurant
(Gaslamp Quarter)
Panelists:
Nina Shah, MD, AstraZeneca
,
Parameswaran N. Hari, MD, MBBS, The Medical College of Wisconsin
,
Maria Chaudhry, Bristol Myers Squibb
and
Christopher Heery, M.D., Arcellx
Disclosures:
Shah: AstraZeneca: Current Employment, Current equity holder in publicly-traded company. Hari: Obsidian Biotherapeutics: Ended employment in the past 24 months; Obsidian Therapeutics: Current Employment. Chaudhry: Bristol Myers Squibb: Current Employment. Heery: Arcellx: Current Employment, Current equity holder in publicly-traded company.
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical Education; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.